GNH USA

Europe — EMA

Iloprost Ratiopharm

GNH USA supplies Iloprost Ratiopharm (Iloprost), a prostacyclin analog for pulmonary arterial hypertension and digital ulcers for severe cases.

Iloprost

Request sourcing

1
Pack/s

What is Iloprost?

Iloprost, the active ingredient in Iloprost Ratiopharm, is a prostacyclin analog presented as a solution for injection for intravenous and subcutaneous use. It treats pulmonary arterial hypertension and related vascular conditions in adult patients.

GNH USA supplies Iloprost Ratiopharm as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

What is Iloprost used for?

Iloprost is indicated for several vascular disorders where prostacyclin pathway modulation improves blood flow.

Pulmonary arterial hypertension: improves exercise capacity and hemodynamic parameters. Digital ulcers associated with systemic sclerosis: promotes ulcer healing and reduces new ulcer formation. Peripheral arterial disease: enhances limb perfusion and alleviates ischemic pain.

What are the side effects of Iloprost?

Common Side Effects: - Flushing - Headache - Nausea - Infusion site pain

Serious or Rare Side Effects: - Severe hypotension - Pulmonary edema - Bleeding complications

What precautions apply to Iloprost?

Precautions should be observed when initiating Iloprost therapy. - Monitor blood pressure: check regularly during and after infusion. - Assess bleeding risk: evaluate platelet function and concurrent anticoagulant use. - Evaluate renal and hepatic function: adjust therapy if significant impairment is present. - Avoid use in uncontrolled hypertension: ensure blood pressure is stable before starting. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Iloprost interact with?

Iloprost may interact with several drug classes.

Major Interactions (Avoid): - Concomitant potent vasodilators (e.g., nitroglycerin): risk of severe hypotension. - Anticoagulants (e.g., warfarin): increased bleeding tendency. - Endothelin receptor antagonists: additive vasodilatory effect.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs: may affect renal function. - Calcium channel blockers: may enhance hypotensive response. - Beta‑blockers: may mask tachycardia associated with hypotension.

Frequently asked questions

What conditions is Iloprost Ratiopharm used to treat?+
Iloprost Ratiopharm is prescribed for pulmonary arterial hypertension, digital ulcers linked to systemic sclerosis, and peripheral arterial disease. In each case, the drug works by dilating blood vessels and inhibiting platelet aggregation, helping to improve blood flow and reduce disease‑related symptoms.
How does Iloprost work in the body?+
Iloprost mimics the natural prostacyclin molecule and activates IP receptors on vascular smooth‑muscle cells. This activation raises intracellular cAMP levels, causing the muscles to relax, which leads to vasodilation, reduced platelet aggregation, and inhibition of abnormal vascular cell growth.
What is the usual dose of Iloprost Ratiopharm?+
The specific dose and infusion schedule of Iloprost Ratiopharm are determined by the prescribing physician based on the patient’s condition, severity, and response to therapy. Dosing is individualized and should follow the prescriber’s written instructions.
Is Iloprost safe to use during pregnancy or breastfeeding?+
The safety of Iloprost in pregnancy and lactation has not been definitively established. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.
How do I order Iloprost Ratiopharm from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and any required import documentation.
How does Iloprost compare with other treatments for pulmonary arterial hypertension?+
Iloprost belongs to the prostacyclin analog class, offering direct vasodilation and antiplatelet effects. Compared with oral endothelin receptor antagonists or phosphodiesterase‑5 inhibitors, Iloprost provides rapid, short‑acting pulmonary vasodilation via intravenous or subcutaneous routes, which can be advantageous for patients needing acute hemodynamic control.
What are the storage and handling requirements for Iloprost Ratiopharm?+
Iloprost Ratiopharm should be stored refrigerated at 2‑8 °C, protected from light, and must not be frozen or shaken. The product should remain in its original packaging until use to maintain stability and potency.
How is Iloprost Ratiopharm administered?+
Iloprost is supplied as a sterile solution for injection and can be given intravenously or subcutaneously. Administration is typically performed by a healthcare professional using an infusion pump or syringe, following the dosing schedule prescribed by the treating physician.
What are the most serious risks associated with Iloprost therapy?+
Serious risks include severe hypotension, pulmonary edema, and significant bleeding. Patients should be closely monitored for sudden drops in blood pressure, respiratory distress, or signs of hemorrhage, and therapy should be adjusted or discontinued if these events occur.
Who should not use Iloprost Ratiopharm?+
Iloprost is contraindicated in patients with known hypersensitivity to iloprost or any component of the formulation, those with uncontrolled systemic hypertension, and individuals experiencing active bleeding or severe hypotension. Clinical judgment is required for patients with significant cardiac or pulmonary instability.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Iloprost
Route
Intravenous Use , Subcutaneous Use
Manufacturer
Ratiopharm Gmbh
Origin
EU

Related products

Calovat

Calovat

Iloprost

Zentiva, K.S.
EU
Iloprost Hameln

Iloprost Hameln

Iloprost

Hameln Pharma Gmbh
EU
Iloprost Rafarm

Iloprost Rafarm

Iloprost

Rafarm Sa.
EU
Iloprost Rafarm

Iloprost Rafarm

Iloprost

Rafarm Sa.
EU